The Kexing vaccine project contracted by the group was delivered for trial production in advance


The Kexing vaccine project contracted by the group was delivered for trial production in advance

On April 11, the Beijing Kexing vaccine project undertaken by Jinhui Group Co., Ltd. was successfully delivered to the owner for trial production nine days ahead of the original plan with the continuous efforts of more than 600 Qi'an employees.

Beijing Kexing Zhongwei project is a major national new crown vaccine production project. The total construction period is only 40 days. After the letter of acceptance was issued, Xu Bing personally took the lead and went to Beijing to set up an excellent team. He mobilized and organized more than 600 workers to plan meticulously and work overtime day and night to overcome many difficulties. He even completed the commissioning and installation of all the equipment in the core part nine days ahead of schedule, created a miracle of construction, successfully delivered it to the owner, and was highly praised by the owner, which fully demonstrated the mission of Kai'an, For the protection of human health, to fight the epidemic has made contributions!

In an interview with the news group of Jinhui group, Xu Bing, the person in charge of Jinhui, was full of emotion and told the story of the arduous journey of fighting for the science and technology development Zhongwei project for 30 days. The biggest difficulty of the project lies in the extremely short construction period, short preparation time, short supply period, more systems, small construction space, more cross operation with civil engineering, more hoisting equipment, more workers, and great management difficulty. However, Jinhui branch, with the strong support of the group company, has the courage to overcome all kinds of unimaginable difficulties, created a myth, and has made remarkable deeds( Jinhui branch / Beijing Branch)

Recommended news


Benchmarking against global standards! The Jotun Zhangjiagang project has successfully passed the safety audit conducted by its Norwegian headquarters.

In mid-September, a foreign‑owned owner‑audit expert team from Jotun’s Norwegian headquarters conducted a three‑day, headquarter‑level specialized safety audit at the Jotun Zhangjiagang project site undertaken by the Group.


The Roche (Shanghai) project of the Group has successfully achieved 2 million safe man-hours.

On September 17, the Roche (Shanghai) Biopharmaceutical Production Base project, undertaken by the Group, successfully reached the milestone of 2 million safe man-hours.


The Group dispatched personnel to attend the training on building trustworthy quality teams in chemical engineering construction.

On September 16–17, the China Chemical Construction Enterprises Association held a training course on building “Quality‑Trusted Work Teams” in Chengdu, with representatives from the Group in attendance. The training featured a live lecture by Shi Jie, a senior expert of the Association.


Good News Abounds | The Group Has Secured Multiple Emerging Industry Projects in Succession

In the golden autumn season, bountiful harvests abound, and new‑generation growth sectors showcase their strength. Since August, leveraging its deep-rooted expertise and core competencies in industrial installation, the Group has successively won bids for five key projects in emerging productivity fields, with a total contract value exceeding RMB 250 million, injecting robust momentum into its resilient year‑end performance.


Two QC achievements of the Group have been awarded at the National Engineering Construction Quality Management Achievement Competition.

Recently, the China Construction Industry Association announced the results of the 2026 Engineering Construction Quality Management Team Achievement Competition. Two QC projects submitted by the Group—“Improving the First-Pass Acceptance Rate for One-Time Forming of Exterior Concrete Moldings” and “Enhancing the First-Pass Welding Acceptance Rate for Dissimilar Steels”—were awarded second and third prizes, respectively.


The Group convened a special meeting to study and implement the spirit of the branch‑company representatives’ symposium.

On the afternoon of August 31, the Group convened a meeting of heads of regional companies and departmental offices in the fourth-floor conference room at its headquarters to deliberate on the implementation of the spirit of the symposium for branch‑office representatives held by the Group on August 30.